Hormonal Imbalances in Prader–Willi and Schaaf–Yang Syndromes Imply the Evolution of Specific Regulation of Hypothalamic Neuroendocrine Function in Mammals
暂无分享,去创建一个
K. Fon Tacer | Rebecca R. Florke Gee | M. Hoyos Sánchez | Tara Bayat | Maria Camila Hoyos Sanchez | R. R. F. Gee
[1] C. Camerino. Oxytocin’s Regulation of Thermogenesis May Be the Link to Prader–Willi Syndrome , 2023, Current issues in molecular biology.
[2] S. Einfeld,et al. The relationship between endogenous oxytocin and vasopressin levels and the Prader-Willi syndrome behaviour phenotype , 2023, Frontiers in Endocrinology.
[3] S. Gygi,et al. MKRN3 inhibits puberty onset via interaction with IGF2BP1 and regulation of hypothalamic plasticity , 2023, JCI insight.
[4] K. Szamotulska,et al. Circulating Levels of Nesfatin-1 and Spexin in Children with Prader-Willi Syndrome during Growth Hormone Treatment and Dietary Intervention , 2023, Nutrients.
[5] M. Butler. Prader–Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review , 2023, International journal of molecular sciences.
[6] M. Krebs,et al. Prader–Willi syndrome: Symptoms and topiramate response in light of genetics , 2023, Frontiers in Neuroscience.
[7] Rodney C. Samaco,et al. Truncated rat Magel2 modelled for the study of Schaaf-Yang syndrome alters select behavioral and physiological outcomes. , 2023, Disease models & mechanisms.
[8] K. Demir,et al. Positive effects of ketogenic diet on weight control in children with obesity due to Prader–Willi syndrome , 2022, Clinical endocrinology.
[9] Kyoko Takano,et al. A nationwide survey of Schaaf-Yang syndrome in Japan , 2022, Journal of Human Genetics.
[10] Simon C Watkins,et al. Insulin secretion deficits in a Prader-Willi syndrome β-cell model are associated with a concerted downregulation of multiple endoplasmic reticulum chaperones , 2022, bioRxiv.
[11] A. Basak,et al. Proteins and proteases of Prader–Willi syndrome: a comprehensive review and perspectives , 2022, Bioscience reports.
[12] D. Molnár,et al. Prader–Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment , 2022, Nutrients.
[13] J. Gaiarsa,et al. Early life oxytocin treatment improves thermo-sensory reactivity and maternal behavior in neonates lacking the autism-associated gene Magel2 , 2022, Neuropsychopharmacology.
[14] D. Turkkahraman,et al. Serum alpha-melanocyte-stimulating hormone (a-MSH), brain-derived neurotrophic factor (BDNF), and agouti-related protein (AGRP) levels in children with Prader-Willi or Bardet-Biedl syndromes , 2022, Journal of Endocrinological Investigation.
[15] E. Jantscher-Krenn,et al. Placental Endocrine Activity: Adaptation and Disruption of Maternal Glucose Metabolism in Pregnancy and the Influence of Fetal Sex , 2021, International journal of molecular sciences.
[16] M. Butler,et al. Hypogonadism in Adult Males with Prader-Willi Syndrome—Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion , 2021, Journal of clinical medicine.
[17] J. Gaiarsa,et al. Oxytocin administration in neonates shapes hippocampal circuitry and restores social behavior in a mouse model of autism , 2021, Molecular Psychiatry.
[18] D. Tautz,et al. Natural copy number variation of tandemly repeated regulatory SNORD RNAs leads to individual phenotypic differences in mice , 2021, Molecular ecology.
[19] J. Fletcher,et al. E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non–small cell lung cancer , 2021, The Journal of experimental medicine.
[20] S. Nelson,et al. Mosaic de novo SNRPN gene variant associated with Prader-Willi syndrome , 2021, Journal of Medical Genetics.
[21] J. Salles,et al. SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome , 2021, Genetics in Medicine.
[22] E. Fliers,et al. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome , 2021, Journal of neuroendocrinology.
[23] C. Schaaf,et al. A retrospective analysis of growth hormone therapy in children with Schaaf–Yang syndrome , 2021, Clinical genetics.
[24] J. Brosius,et al. A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research , 2021, International journal of molecular sciences.
[25] Xiaoxu Tian,et al. MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty , 2021, Nucleic acids research.
[26] C. Höybye,et al. Prader–Willi Syndrome and Hypogonadism: A Review Article , 2021, International journal of molecular sciences.
[27] M. Tauber,et al. Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. , 2021, The lancet. Diabetes & endocrinology.
[28] N. Longo,et al. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review , 2021, International journal of molecular sciences.
[29] M. Maghnie,et al. Sleep disorders in Prader-Willi syndrome, evidence from animal models and humans. , 2021, Sleep medicine reviews.
[30] C. Schaaf,et al. The adult phenotype of Schaaf-Yang syndrome , 2020, Orphanet Journal of Rare Diseases.
[31] K. Fon Tacer,et al. Emerging roles of the MAGE protein family in stress response pathways , 2020, The Journal of Biological Chemistry.
[32] J. Diedrich,et al. Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production , 2020, JCI insight.
[33] Stormy J. Chamberlain,et al. Prader-Willi syndrome: reflections on seminal studies and future therapies , 2020, Open Biology.
[34] M. Hill,et al. Systematic investigation of imprinted gene expression and enrichment in the mouse brain explored at single-cell resolution , 2020, bioRxiv.
[35] Jia-Da Li,et al. Necdin regulates BMAL1 stability and circadian clock through SGT1-HSP90 chaperone machinery , 2020, Nucleic acids research.
[36] Shondra M. Pruett-Miller,et al. Translational Repression of G3BP in Cancer and Germ Cells Suppresses Stress Granules and Enhances Stress Tolerance. , 2020, Molecular cell.
[37] Hilal Sekizkardes,et al. Heterozygous deletions in MKRN3 cause central precocious puberty without Prader-Willi Syndrome. , 2020, The Journal of clinical endocrinology and metabolism.
[38] C. A. Toro,et al. MKRN3 inhibits the reproductive axis through actions in kisspeptin-expressing neurons. , 2020, The Journal of clinical investigation.
[39] S. McCandless,et al. SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims , 2020, Journal of the Endocrine Society.
[40] C. Alves,et al. Prader-Willi syndrome: endocrine manifestations and management , 2020, Archives of endocrinology and metabolism.
[41] E. Hovig,et al. Loss of Snord116 impacts lateral hypothalamus, sleep and food-related behaviors. , 2020, JCI insight.
[42] M. Min,et al. Firing activity of locus coeruleus noradrenergic neurons decreases in necdin-deficient mice, an animal model of Prader–Willi syndrome , 2020, Journal of Neurodevelopmental Disorders.
[43] Yixue Li,et al. MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3 , 2020, National science review.
[44] Igor Ribeiro Ferreira,et al. Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome , 2019, Front. Endocrinol..
[45] M. Butler,et al. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update , 2019, Current pediatric reviews.
[46] Shondra M. Pruett-Miller,et al. MAGE cancer-testis antigens protect the mammalian germline under environmental stress , 2019, Science Advances.
[47] R. Carroll,et al. MKRN3 Mutations in Central Precocious Puberty: A Systematic Review and Meta-Analysis , 2019, Journal of the Endocrine Society.
[48] R. Wevrick,et al. Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis , 2019, Molecular therapy. Methods & clinical development.
[49] M. Varjosalo,et al. MKRN3 Interacts With Several Proteins Implicated in Puberty Timing but Does Not Influence GNRH1 Expression , 2019, Front. Endocrinol..
[50] N. Benvenisty,et al. Genomic Imprinting and Physiological Processes in Mammals , 2019, Cell.
[51] D. Atasoy,et al. Inactivation of Magel2 suppresses oxytocin neurons through synaptic excitation-inhibition imbalance , 2019, Neurobiology of Disease.
[52] B. Crespi,et al. Baby food and bedtime: Evidence for opposite phenotypes from different genetic and epigenetic alterations in Prader-Willi and Angelman syndromes , 2019, SAGE open medicine.
[53] J. Charrow,et al. Schaaf‐Yang syndrome overview: Report of 78 individuals , 2018, American journal of medical genetics. Part A.
[54] S. Duarte,et al. Loss of hierarchical imprinting regulation at the Prader–Willi/Angelman syndrome locus in human iPSCs , 2018, Human molecular genetics.
[55] E. Burstein,et al. Endosomal receptor trafficking: Retromer and beyond , 2018, Traffic.
[56] K. Fisher,et al. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome , 2018, Journal of pediatric endocrinology & metabolism : JPEM.
[57] D. J. Driscoll,et al. Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study , 2018, Journal of Medical Genetics.
[58] Jack Humphrey,et al. A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome , 2018, Cell reports.
[59] C. Schaaf,et al. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome , 2018, Journal of Medical Genetics.
[60] S. O’Rahilly,et al. Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome , 2018, The Journal of clinical investigation.
[61] J. Tavernier,et al. The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways , 2017, Human molecular genetics.
[62] P. Gaspar,et al. Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi syndrome , 2017, eLife.
[63] Jinsup Kim,et al. Prevalence and risk factors for type 2 diabetes mellitus with Prader–Willi syndrome: a single center experience , 2017, Orphanet Journal of Rare Diseases.
[64] P. Lundquist,et al. A novel deletion of SNURF/SNRPN exon 1 in a patient with Prader-Willi-like phenotype. , 2017, European journal of medical genetics.
[65] Huifang Liu,et al. Mkrn3 functions as a novel ubiquitin E3 ligase to inhibit Nptx1 during puberty initiation , 2017, Oncotarget.
[66] P. Potts,et al. Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2. , 2017, The Biochemical journal.
[67] C. Schaaf,et al. Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty , 2017, Genes, brain, and behavior.
[68] M. Butler,et al. Survival Trends from the Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey , 2017, Genetics in Medicine.
[69] D. J. Driscoll,et al. Oxytocin treatment in children with Prader–Willi syndrome: A double‐blind, placebo‐controlled, crossover study , 2017, American journal of medical genetics. Part A.
[70] Yuanyuan Xie,et al. Development of the hypothalamus: conservation, modification and innovation , 2017, Development.
[71] D. J. Driscoll,et al. Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome , 2016, The Journal of clinical investigation.
[72] M. Butler,et al. Causes of Death in Prader-Willi Syndrome: Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey , 2016, Genetics in Medicine.
[73] M. Rigla,et al. Lack of Postprandial Peak in Brain-Derived Neurotrophic Factor in Adults with Prader-Willi Syndrome , 2016, PloS one.
[74] D. J. Driscoll,et al. Higher plasma orexin a levels in children with Prader–Willi syndrome compared with healthy unrelated sibling controls , 2016, American journal of medical genetics. Part A.
[75] C. Cheon. Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome , 2016, Annals of pediatric endocrinology & metabolism.
[76] A. Latronico,et al. A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy , 2016, Archives of endocrinology and metabolism.
[77] A. Sartorio,et al. Growth hormone therapy for Prader–willi syndrome: challenges and solutions , 2016, Therapeutics and clinical risk management.
[78] J. Rosenfeld,et al. The phenotypic spectrum of Schaaf-Yang syndrome – 18 new affected individuals from 14 families , 2016, Genetics in Medicine.
[79] D. J. Driscoll,et al. Elevated plasma oxytocin levels in children with Prader–Willi syndrome compared with healthy unrelated siblings , 2016, American journal of medical genetics. Part A.
[80] C. Schaaf,et al. Prader-Willi Syndrome and Schaaf-Yang Syndrome: Neurodevelopmental Diseases Intersecting at the MAGEL2 Gene , 2016, Diseases.
[81] S. Nishino,et al. Decline of CSF orexin (hypocretin) levels in Prader–Willi syndrome , 2016, American journal of medical genetics. Part A.
[82] L. Campbell,et al. Snord116 is critical in the regulation of food intake and body weight , 2016, Scientific Reports.
[83] L. Zwaigenbaum,et al. Autism spectrum disorder in Prader–Willi syndrome: A systematic review , 2015, American journal of medical genetics. Part A.
[84] V. Gross‐Tsur,et al. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade. , 2015, Human reproduction.
[85] I. Gut,et al. Truncating Mutations of MAGEL2, a Gene within the Prader-Willi Locus, Are Responsible for Severe Arthrogryposis. , 2015, American journal of human genetics.
[86] Evdokia Anagnostou,et al. Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits , 2015, Front. Neurosci..
[87] J. Rosenfeld,et al. USP7 Acts as a Molecular Rheostat to Promote WASH-Dependent Endosomal Protein Recycling and Is Mutated in a Human Neurodevelopmental Disorder. , 2015, Molecular cell.
[88] D. J. Driscoll,et al. EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME. , 2015, The Journal of rare disorders.
[89] Ying Zhang,et al. Spexin peptide is expressed in human endocrine and epithelial tissues and reduced after glucose load in type 2 diabetes , 2015, Peptides.
[90] M. Butler,et al. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings , 2015, Journal of Endocrinological Investigation.
[91] M. Andermann,et al. Ghrelin , 2015, Molecular metabolism.
[92] D. J. Driscoll,et al. Hyperghrelinemia in Prader‐Willi syndrome begins in early infancy long before the onset of hyperphagia , 2015, American journal of medical genetics. Part A.
[93] A. Riva,et al. Influence of the Prader-Willi syndrome imprinting center on the DNA methylation landscape in the mouse brain , 2014, Epigenetics.
[94] B. Whitelaw,et al. Promoter characterization and functional association with placenta of porcine MAGEL2. , 2014, Gene.
[95] J. Peters. The role of genomic imprinting in biology and disease: an expanding view , 2014, Nature Reviews Genetics.
[96] J. Cavaille,et al. Highly restricted deletion of the SNORD116 region is implicated in Prader–Willi Syndrome , 2014, European Journal of Human Genetics.
[97] Robert N. Plasschaert,et al. Genomic imprinting in development, growth, behavior and stem cells , 2014, Development.
[98] S. Bens,et al. Clinical phenotypes of MAGEL2 mutations and deletions , 2014, Orphanet Journal of Rare Diseases.
[99] J. Hirschhorn,et al. Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3. , 2014, The Journal of clinical endocrinology and metabolism.
[100] A. Meyer,et al. The Imprinted NPAP1 Gene in the Prader–Willi Syndrome Region Belongs to a POM121-Related Family of Retrogenes , 2014, Genome biology and evolution.
[101] Hae-sang Lee,et al. Central precocious puberty in a girl with Prader-Willi syndrome , 2013, Journal of pediatric endocrinology & metabolism : JPEM.
[102] A. Gautreau,et al. Retromer-mediated endosomal protein sorting: all WASHed up! , 2013, Trends in cell biology.
[103] B. Peters,et al. Truncating mutations of MAGEL2cause Prader-Willi phenotypes and autism , 2013, Nature Genetics.
[104] C. Deal,et al. Thyroid function from birth to adolescence in Prader-Willi syndrome. , 2013, The Journal of pediatrics.
[105] F. Michel,et al. Stochastic Loss of Silencing of the Imprinted Ndn/NDN Allele, in a Mouse Model and Humans with Prader-Willi Syndrome, Has Functional Consequences , 2013, PLoS genetics.
[106] A. Salvatoni,et al. Central adrenal insufficiency in young adults with Prader‐Willi Syndrome , 2013, Clinical endocrinology.
[107] J. Hirschhorn,et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. , 2013, The New England journal of medicine.
[108] R. Wevrick,et al. Recommendations for the investigation of animal models of Prader–Willi syndrome , 2013, Mammalian Genome.
[109] H. Herzog,et al. Mouse models of Prader–Willi Syndrome: A systematic review , 2013, Frontiers in Neuroendocrinology.
[110] Zhijian J. Chen,et al. Regulation of WASH-Dependent Actin Polymerization and Protein Trafficking by Ubiquitination , 2013, Cell.
[111] W. Colmers,et al. Magel2 Is Required for Leptin-Mediated Depolarization of POMC Neurons in the Hypothalamic Arcuate Nucleus in Mice , 2013, PLoS genetics.
[112] V. Matarazzo,et al. Natural breaking of the maternal silence at the mouse and human imprinted Prader-Willi locus , 2013, Rare diseases.
[113] M. Bertrand,et al. Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus. , 2012, Human molecular genetics.
[114] M. Seaman. The retromer complex – endosomal protein recycling and beyond , 2012, Journal of Cell Science.
[115] B. Horsthemke,et al. The imprinted NPAP1/C15orf2 gene in the Prader-Willi syndrome region encodes a nuclear pore complex associated protein. , 2012, Human molecular genetics.
[116] D. Teis,et al. The ESCRT machinery , 2012, Current Biology.
[117] J. Resnick,et al. Temporal and developmental requirements for the Prader–Willi imprinting center , 2012, Proceedings of the National Academy of Sciences.
[118] D. Barlow. Genomic imprinting: a mammalian epigenetic discovery model. , 2011, Annual review of genetics.
[119] D. J. Driscoll,et al. Unique and atypical deletions in Prader–Willi syndrome reveal distinct phenotypes , 2011, European Journal of Human Genetics.
[120] G. Hertz,et al. Prader-Willi syndrome: A primer for clinicians , 2011, International journal of pediatric endocrinology.
[121] E. Dykens,et al. Prader–Willi syndrome and autism spectrum disorders: an evolving story , 2011, Journal of Neurodevelopmental Disorders.
[122] E. Keverne,et al. Placental protection of the fetal brain during short-term food deprivation , 2011, Proceedings of the National Academy of Sciences.
[123] R. Miyata,et al. Decrease in acetylcholinergic neurons in the pedunculopontine tegmental nucleus in a patient with Prader‐Willi syndrome , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.
[124] D. C. Driscoll,et al. Nutritional phases in Prader–Willi syndrome , 2011, American journal of medical genetics. Part A.
[125] Y. Sohn,et al. Delayed Response of Amylin Levels after an Oral Glucose Challenge in Children with Prader-Willi Syndrome , 2011, Yonsei medical journal.
[126] R. Wevrick,et al. Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice. , 2011, Endocrinology.
[127] F. Watrin,et al. A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene. , 2010, Human molecular genetics.
[128] S. Grambow,et al. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. , 2010, The Journal of clinical endocrinology and metabolism.
[129] P. Crock,et al. Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome. , 2010, The Journal of clinical endocrinology and metabolism.
[130] A. Belgorosky,et al. Thyroid axis dysfunction in patients with Prader‐Willi syndrome during the first 2 years of life , 2010, Clinical endocrinology.
[131] Maojun Yang,et al. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. , 2010, Molecular cell.
[132] S. Luo,et al. High-Resolution Analysis of Parent-of-Origin Allelic Expression in the Mouse Brain , 2010, Science.
[133] J. Rosenfeld,et al. Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader–Willi syndrome , 2010, European Journal of Human Genetics.
[134] J. Christiansen,et al. Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome. , 2010, The Journal of clinical endocrinology and metabolism.
[135] E. Nillni. Regulation of the hypothalamic Thyrotropin Releasing Hormone (TRH) neuron by neuronal and peripheral inputs , 2010, Frontiers in Neuroendocrinology.
[136] M. Y. Kim,et al. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children. , 2010, The Journal of clinical endocrinology and metabolism.
[137] S. O’Rahilly,et al. A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. , 2009, Human molecular genetics.
[138] B. Grant,et al. Pathways and mechanisms of endocytic recycling , 2009, Nature Reviews Molecular Cell Biology.
[139] F. Benarroch,et al. Primary Ovarian Dysfunction Contributes to the Hypogonadism in Women with Prader-Willi Syndrome , 2009, Hormone Research in Paediatrics.
[140] J. Graves,et al. Evolution of genomic imprinting: insights from marsupials and monotremes. , 2009, Annual review of genomics and human genetics.
[141] R. Hochstenbach,et al. A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader–Willi syndrome , 2009, European Journal of Human Genetics.
[142] R. Wevrick,et al. Loss of Magel2, a Candidate Gene for Features of Prader-Willi Syndrome, Impairs Reproductive Function in Mice , 2009, PloS one.
[143] R. Wevrick,et al. Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development. , 2008, Human molecular genetics.
[144] F. Ceccato,et al. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency. , 2008, Journal of endocrinological investigation.
[145] B. Horsthemke,et al. Mechanisms of imprinting of the Prader–Willi/Angelman region , 2008, American journal of medical genetics. Part A.
[146] L. Wilkinson,et al. Imprinted genes and neuroendocrine function , 2008, Frontiers in Neuroendocrinology.
[147] Marwan Shinawi,et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster , 2008, Nature Genetics.
[148] F. Sweep,et al. High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. , 2008, The Journal of clinical endocrinology and metabolism.
[149] B. Lowell,et al. Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. , 2008, The Journal of clinical investigation.
[150] U. Francke,et al. SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice , 2008, PloS one.
[151] D. J. Driscoll,et al. Pituitary abnormalities in Prader–Willi syndrome and early onset morbid obesity , 2008, American journal of medical genetics. Part A.
[152] A. Holland,et al. The phenomenology and diagnosis of psychiatric illness in people with Prader–Willi syndrome , 2008, Psychological Medicine.
[153] S. Grambow,et al. Altered distribution of adiponectin isoforms in children with Prader–Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones , 2007, Clinical endocrinology.
[154] M. Tauber,et al. KIGS Highlights: Growth Hormone Treatment in Prader-Willi Syndrome , 2007, Hormone Research in Paediatrics.
[155] C. Stewart,et al. Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. , 2007, Human molecular genetics.
[156] M. P. Howell,et al. The imprinted gene Magel2 regulates normal circadian output , 2007, Nature Genetics.
[157] H. Duivenvoorden,et al. Thyroid hormone levels in children with Prader–Willi syndrome before and during growth hormone treatment , 2007, Clinical endocrinology.
[158] M. Butler,et al. Plasma obestatin and ghrelin levels in subjects with Prader–Willi syndrome , 2007, American journal of medical genetics. Part A.
[159] D. J. Driscoll,et al. Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader–Willi syndrome , 2007, American journal of medical genetics. Part A.
[160] M. Theodoro,et al. Thyroid function studies in Prader–Willi syndrome , 2007, American journal of medical genetics. Part A.
[161] M. Solimena,et al. Biogenesis of secretory granules. , 2006, Current opinion in cell biology.
[162] Takaaki Kuwajima,et al. Necdin Promotes GABAergic Neuron Differentiation in Cooperation with Dlx Homeodomain Proteins , 2006, The Journal of Neuroscience.
[163] L. Enquist,et al. Olfactory Inputs to Hypothalamic Neurons Controlling Reproduction and Fertility , 2005, Cell.
[164] R. Ahima,et al. Hormonal and metabolic defects in a prader-willi syndrome mouse model with neonatal failure to thrive. , 2005, Endocrinology.
[165] R. Vettor,et al. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance. , 2005, The Journal of clinical endocrinology and metabolism.
[166] K. Kangawa,et al. Ghrelin: structure and function. , 2005, Physiological reviews.
[167] D. J. Driscoll,et al. Prader-Willi syndrome. , 1984, Current problems in pediatrics.
[168] E. Mignot,et al. Hypocretin deficiency in Prader–Willi syndrome , 2005, European journal of neurology.
[169] A. Razin,et al. Establishing the epigenetic status of the Prader-Willi/Angelman imprinting center in the gametes and embryo. , 2004, Human molecular genetics.
[170] J. Frystyk,et al. Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. , 2004, European journal of endocrinology.
[171] Z. Talebizadeh,et al. Plasma Peptide YY and Ghrelin Levels in Infants and Children with Prader-Willi Syndrome , 2004, Journal of pediatric endocrinology & metabolism : JPEM.
[172] S. Batalov,et al. A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[173] S. Lanzendorf,et al. Expression of mRNAs for DNA methyltransferases and methyl‐CpG‐binding proteins in the human female germ line, preimplantation embryos, and embryonic stem cells , 2004, Molecular reproduction and development.
[174] M. Thorén,et al. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[175] J. Bunt,et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. , 2002, The Journal of clinical endocrinology and metabolism.
[176] A. Razin,et al. The imprinting mechanism of the Prader–Willi/Angelman regional control center , 2002, The EMBO journal.
[177] A. Holland,et al. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. , 2002, Developmental medicine and child neurology.
[178] A. Orth,et al. Large-scale analysis of the human and mouse transcriptomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[179] Jimmy D Bell,et al. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. , 2002, The American journal of clinical nutrition.
[180] A. Holland,et al. Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy , 2002, The Lancet.
[181] L. Seoane,et al. Neuropeptide Y, but Not Agouti-Related Peptide or Melanin-Concentrating Hormone, Is a Target Peptide for Orexin-A Feeding Actions in the Rat Hypothalamus , 2002, Neuroendocrinology.
[182] A. Hüttenhofer,et al. The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. , 2001, Human molecular genetics.
[183] J. Walter,et al. Maternal methylation imprints on human chromosome 15 are established during or after fertilization , 2001, Nature Genetics.
[184] A. Hüttenhofer,et al. Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[185] D. Abrous,et al. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. , 2000, Human molecular genetics.
[186] A. Razin,et al. The imprinting box of the Prader-Willi/Angelman syndrome domain , 2000, Nature Genetics.
[187] A. Moncla,et al. Auxological and Endocrine Evolution of 28 Children with Prader-Willi Syndrome: Effect of GH Therapy in 14 Children , 2000, Hormone Research in Paediatrics.
[188] S. Saitoh,et al. Parent-of-origin specific histone acetylation and reactivation of a key imprinted gene locus in Prader-Willi syndrome. , 2000, American journal of human genetics.
[189] R. Nicholls,et al. The ancient source of a distinct gene family encoding proteins featuring RING and C(3)H zinc-finger motifs with abundant expression in developing brain and nervous system. , 2000, Genomics.
[190] B. Horsthemke,et al. Identification of a testis-specific gene (C15orf2) in the Prader-Willi syndrome region on chromosome 15. , 2000, Genomics.
[191] J. Santiago,et al. Leptin concentrations in Prader‐Willi syndrome before and after growth hormone replacement , 2000, Clinical endocrinology.
[192] B. Horsthemke,et al. A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp , 1999, Human Genetics.
[193] A. Berns,et al. In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3 , 1999, Mechanisms of Development.
[194] C. Stewart,et al. Disruption of the mouse necdin gene results in early post-natal lethality , 1999, Nature Genetics.
[195] T A Gray,et al. An imprinted, mammalian bicistronic transcript encodes two independent proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[196] D. J. Driscoll,et al. A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. , 1999, Human molecular genetics.
[197] D. J. Driscoll,et al. Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region. , 1999, Human molecular genetics.
[198] U. Francke,et al. In vivo nuclease hypersensitivity studies reveal multiple sites of parental origin-dependent differential chromatin conformation in the 150 kb SNRPN transcription unit. , 1999, Human molecular genetics.
[199] J. Leckman,et al. Cerebrospinal fluid levels of oxytocin in Prader–Willi syndrome: a preliminary report , 1998, Biological Psychiatry.
[200] M. Butler,et al. Comparison of leptin protein levels in Prader-Willi syndrome and control individuals. , 1998, American journal of medical genetics.
[201] F. Lönnqvist,et al. Increased Leptin Messenger RNA and Serum Leptin Levels in Children with Prader-Willi Syndrome and Nonsyndromal Obesity , 1997, Pediatric Research.
[202] M. Mattei,et al. The Mouse Necdin Gene Is Expressed from the Paternal Allele Only and Lies in the 7C Region of the Mouse Chromosome 7, a Region of Conserved Synteny to the Human Prader-Willi Syndrome Region , 1997, European journal of human genetics : EJHG.
[203] P. Putnam,et al. Rectal bleeding in Prader-Willi syndrome. , 1996, Pediatrics.
[204] D. J. Driscoll,et al. Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. , 1996, American journal of human genetics.
[205] D. Swaab,et al. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. , 1995, The Journal of clinical endocrinology and metabolism.
[206] T. Moore,et al. Genomic imprinting in mammalian development: a parental tug-of-war. , 1991, Trends in genetics : TIG.
[207] M. Butler. Prader-Willi syndrome: current understanding of cause and diagnosis. , 1990, American journal of medical genetics.
[208] G. Bray,et al. The Prader‐Willi Syndrome: A Study of 40 Patients and a Review of the Literature , 1983, Medicine.
[209] M. Tauber,et al. Prader-Willi syndrome: Hormone therapies. , 2021, Handbook of clinical neurology.
[210] D. G. Osborne,et al. Monitoring receptor trafficking following retromer and WASH deregulation. , 2015, Methods in cell biology.
[211] R. Ebstein,et al. The role of oxytocin and vasopressin in emotional and social behaviors. , 2014, Handbook of clinical neurology.
[212] H. Gerdes,et al. Maturation of secretory granules. , 2010, Results and problems in cell differentiation.
[213] D. J. Driscoll,et al. Prader–Willi syndrome , 2009, European Journal of Human Genetics.
[214] A. Holland,et al. The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment. , 2007, Journal of intellectual disability research : JIDR.
[215] Sang Eun Kim,et al. Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[216] R. Nicholls,et al. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. , 2001, Annual review of genomics and human genetics.